Lazaga, Conchita T.
HRN: 24-01-91 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/05/2023
METRONIDAZOLE 500MG (TAB)
11/05/2023
11/11/2023
ORAL
500mg
Tid
Ameobiasis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes